Similar articles for PMID: 28385792

Year	Number of Results
1950	1
1951	1
1952	1
1953	3
1954	3
1956	3
1959	2
1960	4
1961	7
1962	7
1963	1
1967	1
1970	1
1988	1
1996	1
2000	1
2001	1
2002	2
2003	1
2004	2
2006	5
2007	3
2008	4
2009	2
2011	3
2012	2
2013	1
2015	3
2016	4
2017	10
2018	1
2023	0

1

Fixed 3.7-GBq ¹³¹I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.

Jentzen W, Nahum AE, Bockisch A, Binse I, Tulchinsky M. Jentzen W, et al. J Nucl Med. 2017 Sep;58(9):1530. doi: 10.2967/jnumed.117.192872. Epub 2017 Apr 6. J Nucl Med. 2017. PMID: 28385792 Free article. No abstract available.

2

Reply: Fixed 3.7-GBq ¹³¹I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.

Deandreis D. Deandreis D. J Nucl Med. 2017 Sep;58(9):1531. doi: 10.2967/jnumed.117.193185. Epub 2017 Apr 27. J Nucl Med. 2017. PMID: 28450565 Free article. No abstract available.

3

Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma.

Van Nostrand D, Atkins F, Moreau S, Aiken M, Kulkarni K, Wu JS, Burman KD, Wartofsky L. Van Nostrand D, et al. Thyroid. 2009 Oct;19(10):1093-8. doi: 10.1089/thy.2008.0339. Thyroid. 2009. PMID: 19732012

4

[Radioactive iodine and thyroid cancer].

VALLEE G, SAVOIE JC. VALLEE G, et al. Ann Radiol (Paris). 1961;4:223-46. Ann Radiol (Paris). 1961. PMID: 13779808 French. No abstract available.

5

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.

BENUA RS, CICALE NR, SONENBERG M, RAWSON RW. BENUA RS, et al. Am J Roentgenol Radium Ther Nucl Med. 1962 Jan;87:171-82. Am J Roentgenol Radium Ther Nucl Med. 1962. PMID: 13867399 No abstract available.

6

[Utilization of scintigraphy in the treatment of malignant tumors of the thyroid gland with radioactive iodine].

FALILEEVA EP. FALILEEVA EP. Vopr Onkol. 1962;8(7):38-43. Vopr Onkol. 1962. PMID: 13891431 Russian. No abstract available.

7

Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.

Tuttle RM, Leboeuf R, Robbins RJ, Qualey R, Pentlow K, Larson SM, Chan CY. Tuttle RM, et al. J Nucl Med. 2006 Oct;47(10):1587-91. J Nucl Med. 2006. PMID: 17015892 Free article.

8

[Problems of dosimetry posed by the utilization of radioactive iodine in the treatment of cancer of the thyroid].

COLIEZ R, TUBIANA M, DUTREIX J. COLIEZ R, et al. J Radiol Electrol Arch Electr Medicale. 1954;35(1-2):22-7. J Radiol Electrol Arch Electr Medicale. 1954. PMID: 13184470 Undetermined Language. No abstract available.

9

[Examination of the neck by means of the gammagram in the postoperative period after surgery of thyroid cancer].

ADRIAN RE, DAVIDOVICH D, SOLIS J. ADRIAN RE, et al. Sem Med. 1961 Jul 31;119:372-7. Sem Med. 1961. PMID: 13859477 Spanish. No abstract available.

10

[A study on the isolation period of patients with metastatic thyroid cancer treated by 131I according to a new guideline].

Tsuchimochi S, Nakajo M, Umanodan T, Fukushima N, Shigaki S, Kiku T. Tsuchimochi S, et al. Kaku Igaku. 2001 Nov;38(6):747-54. Kaku Igaku. 2001. PMID: 11806086 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed